Simplex Trading’s Nuvation Bio NUVB Stock Holding History

Simplex Trading’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Sell	23,600 -210,000	-90%	-$1.17M	﹤0.01%	5070
2025 Q4	$2.09M	Sell	233,600 -73,100	-24%	-$453K	﹤0.01%	1939
2025 Q3	$1.13M	Buy	+306,700	New	+$836K	﹤0.01%	2933
2025 Q2	–	Sell	-2,000	Closed	-$3K	–	9408
2025 Q1	$3K	Sell	2,000 -133,200	-99%	-$303K	﹤0.01%	7847
2024 Q4	$359K	Sell	135,200 -2,100	-2%	-$5.41K	﹤0.01%	3878
2024 Q3	$314K	Buy	137,300 +136,800	+27,360%	+$417K	﹤0.01%	4075
2024 Q2	$1K	Buy	+500	New	+$1.53K	﹤0.01%	8510
2021 Q4	–	Sell	-3,800	Closed	-$35K	–	11117
2021 Q3	$35K	Hold	3,800	–	–	﹤0.01%	7955
2021 Q2	$35K	Buy	+3,800	New	+$43.3K	﹤0.01%	8086

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's NUVB Position: Q1 2026 in Review

Simplex Trading opened a new position in Nuvation Bio (NUVB) in Q1 2026: 34,338 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4652 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NUVB as recently as Q3 2025.

Simplex Trading first reported a position in NUVB in Q2 2021 and has held it in 11 quarters since. The position peaked at $427K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Simplex Trading held 34,338 shares of Nuvation Bio worth $147K as of Q1 2026.
Nuvation Bio was a new Simplex Trading position in Q1 2026.
Nuvation Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4652 holding.
Simplex Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 11 quarters since.
Simplex Trading's Nuvation Bio position peaked at $427K in Q3 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.